Join FHCO to Learn About the Female Condom and Global HIV/AIDS Prevention Live on MN1.com
05 Julho 2007 - 7:03PM
PR Newswire (US)
CHICAGO, July 5 /PRNewswire-FirstCall/ -- The Female Health Company
(OTC:FHCO) (BULLETIN BOARD: FHCO) , O.B. Parrish, C.E.O. of Female
Health Co. will be featured live on Market News First
(http://www.mn1.com/) for an exclusive interview with MN1's Rich
Hancock. The interview is scheduled for Friday, July 6, 2007, at
1:00pm CDT. The Female Health Company also announced today that the
company has been approved for listing on the American Stock
Exchange. The approval is contingent upon the Company being in
compliance with all applicable listing standards on the date it
begins trading on the Exchange, and may be rescinded if the Company
is not in compliance with such standards. The company will trade
under the symbol FHC. Trading is expected to begin when the market
opens on Monday July 9, 2007. O.B. Parrish, Chairman and C.E.O.,
stated "This listing on the American Stock Exchange marks an
exciting new chapter for The Female Health Company and its
investors. We believe this will provide increased investor exposure
and interest in The Female Health Company." About The Female Health
Company, Inc. -- The Female Health Company, based in Chicago,
Illinois, manufactures and markets the FC Female Condom(R), which
is primarily distributed by public health organizations and donor
groups in over 90 developing countries around the world.
World-wide, the Female Condom is available in various programs in
108 countries. The Company owns certain worldwide rights to the FC
Female Condom(R), including patents that have been issued in the
United States, United Kingdom, Japan, France, Italy, Germany,
Spain, the European Patent Convention, the People's Republic of
China, Canada, South Korea and Australia. FC Female Condom(R) is
the only available FDA-approved product controlled by a woman that
offers dual protection against sexually transmitted diseases,
including HIV/AIDS, and unintended pregnancy. "Safe Harbor"
statement under the Private Securities Litigation Reform Action of
1995: The statements in this release which are not historical fact
are forward-looking statements based upon the Company's current
plans and strategies, and reflect the Company's current assessment
of the risks and uncertainties related to its business, including
such things as product demand and market acceptance; the economic
and business environment and the impact of government pressures;
currency risks; capacity; efficiency and supply constraints; and
other risks detailed in the Company's press releases, shareholder
communications and Securities and Exchange Commission filings.
Actual events affecting the Company and the impact of such events
on the Company's operations may vary from those currently
anticipated. For more information about the Female Health Company
visit the Company's web site at http://www.femalehealth.com/ and
http://www.femalecondom.org/. If you would like to be added to an
e-mail alert list, please send an e-mail to DATASOURCE: The Female
Health Company CONTACT: William R. Gargiulo, Jr., +1-231-526-1244,
or Donna Felch, +1-312-595-9123, both for The Female Health Company
Web site: http://www.femalehealth.com/ http://www.femalecondom.org/
http://www.mn1.com/
Copyright